Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting Hartley will also present new data on Orion’s CCR2 antagonist, OB-004, demonstrating the ability of this

Oliver Hartley, Dr. Pierre Eftekhari, Dr. Lauren Slosky, Dr. Christel Menet, Dr. Ben Myers and Dr.

Oliver Hartley. Below is your Classified GPCR News at a glance for March 20th to 26th, 2023.

Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases

Oliver Hartley, was at the PEGS Europe Novartis pays Legend $100M upfront to give solid tumor CAR-T the

Live AMAs and workshops are where the thinking comes alive, and where the question you've been sitting

Kenakin, with structured lessons as the foundation and live AMAs and workshops where the thinking comes alive

Realizing tissue is alive, unpredictable, and full of hidden structure.

Relevant Publications Development of Orion’s platform technology Hartley, O. et al. (2004) Proceedings

these bottlenecks using the field-tested decision logic  of one of the most experienced pharmacologists alive

Everything remains alive. This creates a subtle but powerful shift.